Baxter International reported a 1 percent profit increase for the fourth-quarter on Thursday, meeting Wall Street expectations but failing to impress analysts accustomed to bigger gains from the medical products maker. The company's broad mix of medically necessary products — including blood plasma, kidney dialysis treatments ...

Specialty drug and device maker Baxter International reports its third-quarter 2009 results Thursday morning. The following is a summary of key developments and analyst commentary for the period. OVERVIEW: Baxter announced several high-profile product launches and agreements during the last three-month period. Last week the Deerfield, Illinois-based company said authorities ...

Specialty drug and medical device maker Baxter International says it is aiming for annual earnings-per-share growth of 11 to 13 percent over the next five years, with sales rising 7 to 8 percent each year. Its sales forecast excludes the effects of foreign currency exchange ...

Specialty drug and medical device maker Baxter International Inc. said Thursday its profit rose 8 percent in the second quarter on better margins, more than offsetting a decline in sales. The company's broad mix of medically necessary products — including blood plasma, kidney dialysis treatments and ...